110 related articles for article (PubMed ID: 35753742)
1. Clinical and prognostic features of 512 cases of cholangiocarcinoma.
Kuang-Zeng S; Rao L; Luo B; Luo L; Liu X
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2020 Nov; 45(11):1283-1290. PubMed ID: 35753742
[TBL] [Abstract][Full Text] [Related]
2. Combined hepatocellular carcinoma-cholangiocarcinoma: MRI features correlated with tumor biomarkers and prognosis.
Zhou C; Wang Y; Ma L; Qian X; Yang C; Zeng M
Eur Radiol; 2022 Jan; 32(1):78-88. PubMed ID: 34279688
[TBL] [Abstract][Full Text] [Related]
3. Adjuvant therapy for cholangiocarcinoma after surgery and prognosis factors for cholangiocarcinoma: A single-center retrospective cohort study.
Sun Z; Han X; You W; Tang J; Xu J; Ye B; Li T; Zhang Y; Chen K; Ding Y; Wang W
Front Oncol; 2023; 13():1116338. PubMed ID: 37007129
[TBL] [Abstract][Full Text] [Related]
4. Correlation Between Adjuvant Chemotherapy Regimen, Recurrence Pattern and Prognosis of Cholangiocarcinoma After Radical Surgery.
Rao L; Ma N; Liu Y; Du L; Qu B
Front Oncol; 2022; 12():695228. PubMed ID: 35223461
[TBL] [Abstract][Full Text] [Related]
5. Serum Levels of Cytokine-Induced Apoptosis Inhibitor 1 (CIAPIN1) as a Potential Prognostic Biomarker of Cholangiocarcinoma.
Truong SDA; Tummanatsakun D; Proungvitaya T; Limpaiboon T; Wongwattanakul M; Chua-On D; Roytrakul S; Proungvitaya S
Diagnostics (Basel); 2021 Jun; 11(6):. PubMed ID: 34201138
[TBL] [Abstract][Full Text] [Related]
6. Clinical correlation of cadherin-17 marker with advanced tumor stages and poor prognosis of cholangiocarcinoma.
Zheng BH; Shen S; Wong KF; Gong ZJ; Sun WT; Ni XJ; Wang JW; Hu MY; Liu H; Ni XL; Liu HB; Luk JM; Suo T
J Surg Oncol; 2021 Apr; 123(5):1253-1262. PubMed ID: 33524213
[TBL] [Abstract][Full Text] [Related]
7. Prediction of Multiple Serum Tumor Markers in Hepatolithiasis Complicated with Intrahepatic Cholangiocarcinoma.
Zhao H; Lu B
Cancer Manag Res; 2022; 14():249-255. PubMed ID: 35082529
[TBL] [Abstract][Full Text] [Related]
8. miR-378 serves as a prognostic biomarker in cholangiocarcinoma and promotes tumor proliferation, migration, and invasion.
Zhou Z; Ma J
Cancer Biomark; 2019; 24(2):173-181. PubMed ID: 30594918
[TBL] [Abstract][Full Text] [Related]
9. Circulating microRNA-21 as a prognostic, biological marker in cholangiocarcinoma.
Liu CH; Huang Q; Jin ZY; Xie F; Zhu CL; Liu Z; Wang C
J Cancer Res Ther; 2018 Jan; 14(1):220-225. PubMed ID: 29516989
[TBL] [Abstract][Full Text] [Related]
10. Construction of a competing endogenous RNA network related to the prognosis of cholangiocarcinoma and comprehensive analysis of the immunological correlation.
Wang N; Zhou Y; Zuo Z; Wang R; Li J; Han T; Yang B
J Gastrointest Oncol; 2021 Oct; 12(5):2287-2309. PubMed ID: 34790393
[TBL] [Abstract][Full Text] [Related]
11. CA 19-9 in combination with abdominal CT scan for the diagnosis of mass-forming intrahepatic cholangiocarcinoma.
Raunroadroong N; Sriplung H; Lertprasertsuke N; Pojchamarnwiputh S; Chiangmai WN; Sinsuwan W; Thongprasert S
Hepat Oncol; 2014 Oct; 1(4):377-386. PubMed ID: 30190973
[TBL] [Abstract][Full Text] [Related]
12. Comparison of concomitant and subsequent cholangiocarcinomas associated with hepatolithiasis: Clinical implications.
Lin CC; Lin PY; Chen YL
World J Gastroenterol; 2013 Jan; 19(3):375-80. PubMed ID: 23372360
[TBL] [Abstract][Full Text] [Related]
13. Meta-analysis of the diagnostic value of Wisteria floribunda agglutinin-sialylated mucin1 and the prognostic role of mucin1 in human cholangiocarcinoma.
Tang Z; Yang Y; Wang X; Meng W; Li X
BMJ Open; 2019 Jan; 9(1):e021693. PubMed ID: 30700476
[TBL] [Abstract][Full Text] [Related]
14. Natural History and Prognostic Factors of Cholangiocarcinoma With Spinal Metastasis: A 10-Year Single Center Study.
Sangsin A; Saiudom D; Pongmanee S; Saengsin J; Leerapun T; Murakami H
Clin Spine Surg; 2018 Apr; 31(3):E160-E165. PubMed ID: 29596214
[TBL] [Abstract][Full Text] [Related]
15. Post-resection prognosis of combined hepatocellular carcinoma-cholangiocarcinoma cannot be predicted by the 2019 World Health Organization classification.
Kim M; Hwang S; Ahn CS; Kim KH; Moon DB; Song GW; Jung DH; Hong SM
Asian J Surg; 2021 Nov; 44(11):1389-1395. PubMed ID: 33766528
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of a panel of cancer stem cell markers enhances the predictive capability of the progression and recurrence in the early stage cholangiocarcinoma.
Padthaisong S; Thanee M; Namwat N; Phetcharaburanin J; Klanrit P; Khuntikeo N; Titapun A; Sungkhamanon S; Saya H; Loilome W
J Transl Med; 2020 Feb; 18(1):64. PubMed ID: 32039729
[TBL] [Abstract][Full Text] [Related]
17. LncRNA CCAT1 as the unfavorable prognostic biomarker for cholangiocarcinoma.
Jiang XM; Li ZL; Li JL; Zheng WY; Li XH; Cui YF; Sun DJ
Eur Rev Med Pharmacol Sci; 2017 Mar; 21(6):1242-1247. PubMed ID: 28387907
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of miR-25 is associated with progression and poor prognosis of cholangiocarcinoma.
Liu H; Ma L; Wang J
Exp Ther Med; 2019 Oct; 18(4):2687-2694. PubMed ID: 31555370
[TBL] [Abstract][Full Text] [Related]
19. The association between circulating MicroRNA-150 level and cholangiocarcinoma.
Salem PES; Ghazala RA; El Gendi AM; Emara DM; Ahmed NM
J Clin Lab Anal; 2020 Nov; 34(11):e23397. PubMed ID: 33161598
[TBL] [Abstract][Full Text] [Related]
20. Cholangiocarcinoma landscape in Europe: Diagnostic, prognostic and therapeutic insights from the ENSCCA Registry.
Izquierdo-Sanchez L; Lamarca A; La Casta A; Buettner S; Utpatel K; Klümpen HJ; Adeva J; Vogel A; Lleo A; Fabris L; Ponz-Sarvise M; Brustia R; Cardinale V; Braconi C; Vidili G; Jamieson NB; Macias RI; Jonas JP; Marzioni M; Hołówko W; Folseraas T; Kupčinskas J; Sparchez Z; Krawczyk M; Krupa Ł; Scripcariu V; Grazi GL; Landa-Magdalena A; Ijzermans JN; Evert K; Erdmann JI; López-López F; Saborowski A; Scheiter A; Santos-Laso A; Carpino G; Andersen JB; Marin JJ; Alvaro D; Bujanda L; Forner A; Valle JW; Koerkamp BG; Banales JM
J Hepatol; 2022 May; 76(5):1109-1121. PubMed ID: 35167909
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
